Recent developments in immune activation by uric acid crystals

Our plain-English summary of Recent developments in immune activation by uric acid crystals, by G. Ng, E.M. Chau, Y. Shi (Archivum Immunologiae et Therapiae Experimentalis, 2010).

The study

• Authors: G. Ng, E.M. Chau, Y. Shi
• Journal: Archivum Immunologiae et Therapiae Experimentalis
• Published: 2010;58(4):273-7
• Type of article: Review
• Cited by: 13 articles, as counted by NIH iCite
• Read it: PubMed · Publisher

Abstract

Uric acid crystals, the causative agent of gout, have recently gained widespread attention due to their role as a natural endogenous adjuvant. Uric acid crystals, first sensed extracellularly by membrane lipid alterations, are internalized and subsequently activate the NLRP3 inflammasome. Currently, various aspects of this particular novel pathway are poorly defined. This short review will focus on some recent discoveries regarding this simple crystalline structure and address areas requiring further investigation. The fact that uric acid crystals activate innate host defense mechanisms, triggering robust inflammation and immune activation, may lead to engineering potent adjuvants for future vaccines. Furthermore, the elucidation of uric acid's mechanism of inflammation may lay the foundation for other solid inflammatory structures such as silica, asbestos, and alum.

In plain English

This article was a short review, not an original study. The authors, from the University of Calgary, summarized published research on how monosodium urate (uric acid) crystals, the cause of gout, activate the immune system and might act as a vaccine adjuvant, which is a substance that strengthens immune responses. They described earlier rheumatology research on proteins binding to the crystal surface. They described other groups' reports that the crystals activate a protein complex inside cells called the NLRP3 inflammasome. They also described their own group's earlier proposal that cells sense the crystals at the cell membrane, before taking them in, by gathering cholesterol-rich lipid regions around them. Asbestos appeared only in passing: the review noted that other studies had implicated silica, asbestos and alum in activating the NLRP3 inflammasome. The review did not study asbestos exposure or any asbestos-related disease in people. Citing reports from other groups and their own unpublished data, the authors suggested that inflammation and adjuvant activity may be two independent events. The authors concluded that adding lipid biology to immunological research may lead to faster development of new vaccines.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: short narrative review of published research
• Who was studied: no study population of its own; the article reviewed published laboratory and clinical research on uric acid crystals
• Exposure: monosodium urate (uric acid) crystals. Asbestos was mentioned only as one of several other solid structures (silica, asbestos, alum) that other studies had implicated in activating the NLRP3 inflammasome
• Main results:
  • The review described a 2006 report by another research group that monosodium urate crystals activate the NLRP3 inflammasome
  • The review described the authors' own group's earlier proposal that cells sense the crystals before taking them in, through a lipid-sorting mechanism at the cell membrane
  • The only asbestos-specific source the review cited was a 2008 study by Dostert et al. on NLRP3 inflammasome sensing of asbestos and silica; the review did not report that study's results in detail
  • Based on other groups' reports and their own unpublished data, the authors suggested that inflammation and adjuvant activity are independent events
• The authors' conclusion: The authors concluded that adding lipid biology to immunological research may lead to accelerated development of new vaccines
• Limitations the authors state:
  • The authors stated that advanced tools for large-scale investigations are currently lacking
  • The authors stated that how NLRP3 affects later immune responses, such as adjuvant activity, is speculative

Topics

Medical terms in this study, explained in our Lexicon: Crystalline, Inflammation.

Related studies

• C3 activation by monosodium urate monohydrate and other crystalline material — P. Hasselbacher (1979)
• Pulmonary toxicants and fibrosis: innate and adaptive immune mechanisms — R. Malaviya, H.M. Kipen, et al. (2020)
• Immunopathological effects of malaria pigment or hemozoin and other crystals — A. Tyberghein, K. Deroost, et al. (2014)
• Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma — S. Rovers, A. Janssens, et al. (2022)
• Simian virus 40, poliovaccines and human tumors: a review of recent developments — M. Carbone, P. Rizzo, et al. (1997)
• Malignant pleural mesothelioma: recent developments — K. Sinn, B. Mosleh, et al. (2021)

Browse return to medical research.